Isolation of three dibenzocyclooctadiene lignans from in vitro cultures of Schisandra chinensis (Turcz.) Baill. - The first report

Pharmazie

Volumn 70, Issue 5, 2014, Pages 337-339

  Szopa, A ^a   Kisiel, W ^b   Ekiert, H ^a   Szewczyk, A ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOALKENE; DEOXYSCHIZANDRIN; GOMISIN A; LIGNAN DERIVATIVE; SCHISANDRA CHINENSIS EXTRACT; SCHIZANDRIN; UNCLASSIFIED DRUG; 1,3 DIOXOLANE DERIVATIVE; CYCLOOCTANE DERIVATIVE; LIGNAN; POLYCYCLIC HYDROCARBON; SCHIZANDRIN A;

ARTICLE; BIOMASS; DRUG ISOLATION; IN VITRO STUDY; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; SCHISANDRA CHINENSIS; SHOOT; CELL CULTURE; CHEMISTRY; CYTOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PLANT; PLANT LEAF; SCHISANDRA; THIN LAYER CHROMATOGRAPHY;

CELLS, CULTURED; CHROMATOGRAPHY, THIN LAYER; CYCLOOCTANES; DIOXOLES; LIGNANS; MAGNETIC RESONANCE SPECTROSCOPY; PLANT LEAVES; PLANT SHOOTS; POLYCYCLIC COMPOUNDS; SCHISANDRA;

EID: 84930623823     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2015.4779     Document Type: Article

References (16)

1. Chu C, Zhang S, Tong S, Li X, Yan J (2013) An efficient strategy for the extraction and purification of lignans from Schisandra chinensis by a combination of supercritical fluid extraction and high-speed counter-current chromatography. J Sep Sci 36: 3958-3964.
2. European Pharmacopoeia 8th (2014) Schisandrae chinensis fructus. European Directorate for the Quality of Medicines, Strasbourg, p. 1381.
3. Hancke JL, Burgos RA, Ahumada F (1999) Schisandra chinensis (Turcz.) Baill. Fitoterapia 70: 451-471.
4. Kochetkov NK, Khorlin AY, Chizhov OS, Sheichenko VI (1961) Schizandrin-lignan of unusual structure. Tetrahedron Lett 2: 730-734.
5. Murashige T, Skoog F (1962) A revised medium for rapid growth and bioassays with tobacco tissue cultures. Physiol Plant 15: 473-497.
6. Murthy K, Mishra S (2009) Quantification of -sitosterol from Mucuna pruriens by TLC. Chromatographia 69: 183-186.
7. Panossian A, Wikman G (2008) Pharmacology of Schisandra chinensis Baill.: An overview of Russian research and uses in medicine. J Ethnopharmacol 118: 183-212.
8. Szopa A, Ekiert H (2011) Lignans in Schisandra chinensis in vitro cultures. Pharmazie 66: 633-634.
9. Szopa A, Ekiert H(2013) Production of deoxyschizandrin and -schizandrin in shoot-differentiating and undifferentiating callus cultures of Schisandra chinensis (Turcz.) Baill. (Chinese magnolia vine). J Biotechnol 165: 209-213.
10. Szopa A, Ekiert H (2014a). Schisandra chinensis (Turcz.) Baill. (Chinese magnolia vine) in vitro cultures, In: Govil JN (ed) Recent Progress in Medicinal Plants. Biotechnology and Genetic Engineering II, vol. 39, Studium Press LLC, Houston, p. 405-434.
11. Szopa A, Ekiert H (2014b) Schisandra chinensis in vitro cultures as a good potential source of therapeutically important lignans: SchizantherinAand gomisin G. Phytochem Lett. DOI: 10.1016/j.phytol.2014.12.022.
12. United States Pharmacopeia (1999) National Formulary.
13. WHO Monographs on Selected Medicinal Plants (2007) Fructus Schisandrae. World Health Organization, vol. 3, Geneva, p. 296-313.
14. Xiao B, Liu X, Hu D, Liu C, Wang X, Yin J (2007) Pharmacognostical study of Folium Schisandrae chinensis. Asian J Trad Med 2: 198-201.
15. Yukinobu I, Heihachiro T, Itiro Y (1979) The constituents of Schisandra chinensis Baill. Isolation and structure determination of five new lignans, gomisin A, B, C, F, G and the absolute structure of schizandrin. Chem Pharm Bull 27: 1382-1394.
16. Zhang H, Zhang G, Zhu Z, Zhao L, Fei Y, Jing J, Chai Y (2009) Determination of six lignans in Schisandra chinensis (Turcz.) Baill. fruits and related Chinese multiherb remedies by HPLC. Food Chem 115: 735-739.